Compare BGI & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BGI | COSM |
|---|---|---|
| Founded | 1879 | 2009 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Other Pharmaceuticals |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.7M | 18.8M |
| IPO Year | 2005 | 2013 |
| Metric | BGI | COSM |
|---|---|---|
| Price | $0.92 | $0.49 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 39.8K | ★ 607.9K |
| Earning Date | 12-05-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $136,846,182.00 | $59,792,819.00 |
| Revenue This Year | N/A | $28.14 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 7.45 | 6.69 |
| 52 Week Low | $0.56 | $0.28 |
| 52 Week High | $2.03 | $1.32 |
| Indicator | BGI | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 29.70 | 43.79 |
| Support Level | $1.00 | $0.48 |
| Resistance Level | $0.93 | $0.52 |
| Average True Range (ATR) | 0.03 | 0.05 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 6.25 | 55.51 |
Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.